We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Synchrony Partners With PSIvet, Expands CareCredit Offering
Read MoreHide Full Article
Synchrony Financial (SYF - Free Report) recently announced that it has partnered with PSIvet to provide the company’s CareCredit health and wellness credit card to pet owners. The card will be offered through more than 5,500 independent veterinary practices PSIvet works with. Convenient financing options will enable pet owners to get the highest level of care for their pets.
The move bodes well for Synchrony, as wider use of CareCredit should boost the top line in the future. This is evident from the partnership that SYF aims to expand its CareCredit offerings to new customers with attention paid to health systems. Health and Wellness accounted for 17.2% of the total interest and fees on loans of SYF in the second quarter of 2024. This partnership will also lead to higher contributions from this segment and a rise in the loan receivables portfolio, leading to higher interest income and fees on loans.
The CareCredit card will allow pet owners to secure financing for all kinds of veterinary services, diagnostics and treatments, expanding their payment options. Pet parents can check if they prequalify for a CareCredit credit card without impacting their credit score in real time. They can apply from any smart device including their phones. Once approved, pet parents can make the payment immediately.
Partnerships similar to the current one are expected to solidify CareCredit’s presence across the pet care space. It partners with veterinary practices aiding these to streamline payment processes, improving cash flows and lowering accounts receivables. CareCredit is presently offered in 25,000-plus vet practices in the United States and expanding the reach of CareCredit financing solutions also bolsters the purchasing power of consumers.
Synchrony’s Price Performance
Shares of Synchrony have gained 18.9% in the past six months compared with the industry’s 11% growth.
Image Source: Zacks Investment Research
SYF’s Zacks Rank & Key Picks
Synchrony currently carries a Zacks Rank #3 (Hold).
The Zacks Consensus Estimate for Jackson Financial’s current-year earnings is pegged at $18.49 per share, which indicates 44% year-over-year growth. It witnessed two upward estimate revisions in the past 60 days against no downward movement. The consensus mark for JXN’s current-year revenues indicates a 116.7% surge from a year ago.
The Zacks Consensus Estimate for Aflac’s current-year earnings is pegged at $6.75 per share, which indicates 8.4% year-over-year growth. It witnessed one upward estimate revision in the past 30 days against no downward movement. AFL beat earnings estimates in three of the past four quarters and missed once, with an average surprise of 8.2%.
The Zacks Consensus Estimate for WisdomTree’s 2024 earnings indicates 67.6% year-over-year growth. In the past two months, WT has witnessed two upward estimate revisions against none in the opposite direction. It beat earnings estimates twice in the past four quarters and met on the other occasions, with an average surprise of 5.9%.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Synchrony Partners With PSIvet, Expands CareCredit Offering
Synchrony Financial (SYF - Free Report) recently announced that it has partnered with PSIvet to provide the company’s CareCredit health and wellness credit card to pet owners. The card will be offered through more than 5,500 independent veterinary practices PSIvet works with. Convenient financing options will enable pet owners to get the highest level of care for their pets.
The move bodes well for Synchrony, as wider use of CareCredit should boost the top line in the future. This is evident from the partnership that SYF aims to expand its CareCredit offerings to new customers with attention paid to health systems. Health and Wellness accounted for 17.2% of the total interest and fees on loans of SYF in the second quarter of 2024. This partnership will also lead to higher contributions from this segment and a rise in the loan receivables portfolio, leading to higher interest income and fees on loans.
The CareCredit card will allow pet owners to secure financing for all kinds of veterinary services, diagnostics and treatments, expanding their payment options. Pet parents can check if they prequalify for a CareCredit credit card without impacting their credit score in real time. They can apply from any smart device including their phones. Once approved, pet parents can make the payment immediately.
Partnerships similar to the current one are expected to solidify CareCredit’s presence across the pet care space. It partners with veterinary practices aiding these to streamline payment processes, improving cash flows and lowering accounts receivables. CareCredit is presently offered in 25,000-plus vet practices in the United States and expanding the reach of CareCredit financing solutions also bolsters the purchasing power of consumers.
Synchrony’s Price Performance
Shares of Synchrony have gained 18.9% in the past six months compared with the industry’s 11% growth.
Image Source: Zacks Investment Research
SYF’s Zacks Rank & Key Picks
Synchrony currently carries a Zacks Rank #3 (Hold).
Investors interested in the broader Finance space may look at some better-ranked players like Jackson Financial Inc. (JXN - Free Report) , Aflac Incorporated (AFL - Free Report) and WisdomTree, Inc. (WT - Free Report) . Each stock presently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for Jackson Financial’s current-year earnings is pegged at $18.49 per share, which indicates 44% year-over-year growth. It witnessed two upward estimate revisions in the past 60 days against no downward movement. The consensus mark for JXN’s current-year revenues indicates a 116.7% surge from a year ago.
The Zacks Consensus Estimate for Aflac’s current-year earnings is pegged at $6.75 per share, which indicates 8.4% year-over-year growth. It witnessed one upward estimate revision in the past 30 days against no downward movement. AFL beat earnings estimates in three of the past four quarters and missed once, with an average surprise of 8.2%.
The Zacks Consensus Estimate for WisdomTree’s 2024 earnings indicates 67.6% year-over-year growth. In the past two months, WT has witnessed two upward estimate revisions against none in the opposite direction. It beat earnings estimates twice in the past four quarters and met on the other occasions, with an average surprise of 5.9%.